Live Markets  BS Home News Now Markets & Investing Companies & Industry  Portfolio TUE 24 NOV, 2009 05:17 AM FEEDBACK 
  Live Markets* > Company Details
Get Quote Search
Stock Quote Glenmark Pharmaceuticals Ltd
BSE: Rs 253.35   -0.75 (-0.30%)
November,23 04:00
NSE: Rs 253.4   -0.45 (-0.18%)
November,23 03:55
Sensex
BSENSE
 
Glenmark Pharmaceuticals Ltd
Sector Gainers
Sector Losers
CompanyLast (Rs)Gain (%)
Aurobindo Pharma852.058.38
Panacea Biotec166.204.99
Themis Medicare148.004.93
Cipla322.004.22
Hind.Bio Science3.284.13
Gufic BioScience6.094.10
Bal Pharma27.153.43
Indoco Remedies274.003.20
(Source: BSE)
 more  
 Financials Results (Quarterly)
 Particulars (Rs lakh) Sep-09 Jun-09
 Sale2361022010
 Other Income262188
 Total expenses1733021372
 Net profit5750522
 Equity26962505
 more  
(Source: BSE)
  Broker Calls
Report Name Broker Name Reco Price View
Glenmark Pharma Emkay Accumulate 230
Glenmark Pharma BRICS Buy 138
Glenmark Pharma Emkay Accumulate 141
Glenmark Pharma Religare Buy 673
Glenmark Pharma Religare Buy 673
Glenmark Pharma Emkay Buy 672
Glenmark Pharma Emkay Buy 449
  Returns (%) more 
Particulars BSE(%) NSE(%) 
One month8.087.76
Six months14.3313.96
One year-19.92-20.22
(Source: BSE)
 
BSE: 532296 | NSE: GLENMARK
 BSENSE
Open 255.00 254.50
Day High 257.00 257.00
Day Low 251.50 250.00
Previous Close 254.10 253.85
52-Week high 346.00 346.80
52-Week low 119.00 119.20
P/E 71.87 71.89
Market Cap (Rs cr) 6832.85 6834.2
Volume 228992.00 775846.00
 Peer Group
Company Last (Rs) Mkt Cap (Rs cr)
Ranbaxy Labs. 421.95 17737
Cipla 322.00 25027
Sun Pharma.Inds. 1466.80 30380
Biocon 276.05 5521
Cadila Health. 571.25 7798
Piramal Health 399.10 8341
(Source: BSE)
 Company Profile - Glenmark Pharma.
Profile
Chairman: Gracias Saldanha
Email: complianceofficer@glenmarkpharma.com
Site Url: http://www.glenmarkpharma.com
Company Address
B/2 Mahalaxmi Chambers
22 Bhulabhai Desai Road Mumbai
Off Western Exp High,Andher(W)
Phone: 91-22-56549999/
Fax: 91-22-23512177/23519652/
 
  Glenmark Pharma. News more 
Glenmark, Medicis sign two agreements
Glenmark Pharma net dips 31%
Glenmark Generics' IPO to raise up to Rs 600 cr
Glenmark raises Rs 413 cr in QIP
Glenmark's flagship drug hope dies in clinical trials
Glenmark faces patent infringement case in US
Glenmark's new diarrhoea drug in final-stage trials
  Performance & Analysis more 
ParticularsBSENSE
EPS (Trailing 12 mnths,Rs)5.825.82
Free Float (%)51.5951.59
FII holding 27.8927.89
ROCE(%)14.8514.85
Face Value (in Rs) 1.00
  Shareholding Pattern more 
ParticularsMar-08Dec-07
Indian promoters1.140.88
Foreign promoters--
Acting person--
Other promoters51.2751.66
MFs/UTI2.392.66
Banks/FIs1.511.54
FIIs27.9426.48
Public corporate bodies1.972.30
Indian public12.4913.23
NRIs/OCBs--
Others1.281.24
No of shares248725752246862687
(Source: BSE)
  
Quick Links
Market News Commodities News
Top Gainers Top Losers
52 Week High 52 Week Low
The Smart Investor Broker calls
BSE Notices IPO
 
Stock Name A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
 
Business Standard Network:  Business Standard.com | BSmotoring.com | BShindi.com | E-paper | Portfolios
ABOUT US PARTNER WITH US JOBS@BS ADVERTISE WITH US TERMS & CONDITIONS SITE MAP CONTACT US
Business Standard Ltd. Copyright & Disclaimer feedback@business-standard.com
This site is best viewed with Internet Explorer 6.0 or higher; Firefox 2.0 or higher at a minimum screen resolution of 1024x768
* Stock quotes delayed by 10 minutes or more. All information provided is on "as is" basis and for information purposes only. Kindly consult your financial advisor or stock broker to verify the accuracy and recency of all the information prior to taking any investment decision. While due diligence is done and care taken prior to uploading the stock price data, neither Business Standard Limited, www.business-standard.com nor any independent service provider is/are liable for any information errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.